A logo Agilent Technologies +
Agilent Technologies
+

Agilent Technologies Overview

Company: Agilent Technologies
CEO: Padraig McDonnell
Founded: 1999
Symbol: A
Exchange: NYSE
Industry: Medical - Diagnostics & Research
Sector: Healthcare
About

Agilent Technologies delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. Thisludes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offeringslude immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary serviceslude expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network,luding direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Continue reading...

Agilent Technologies (A)

  • Stock Price
  • Volume
134.04 -14.59 -9.82%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Agilent Technologies annual revenue was $6.95 B in 2025.

Net Income

Agilent Technologies annual net income was $1.30 B in 2025.

Employees

Agilent Technologies annual employee count was 18,100 in 2025.

Revenue by Segment

Agilent Technologies’s revenue by segment: Agilent CrossLab: $2.91 B, Applied Markets: $1.31 B and Life Sciences and Applied Markets: $2.73 B in 2025.

Revenue by Region

Agilent Technologies’s revenue by region: Americas: $2.81 B, Asia Pacific: $2.22 B and Europe: $1.92 B in 2025.

Executive Salary

Padraig McDonnell President; Chief Executive Officer, at Agilent Tec...

Revenue per Employee

Agilent Technologies revenue per employee was $383.87 K in 2025.

Profit per Employee

Agilent Technologies profit per employee was $71.99 K in 2025.

Income Statement

Operating Income

Agilent Technologies annual operating income was $1.48 B in 2025.

Research & Development

Agilent Technologies annual research & development expense was $455.00 M in 2025.

Tax Rate (%)

Agilent Technologies annual Tax Rate was 9.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

Agilent Technologies annual total assets was $12.73 B in 2025.

Total Liabilities

Agilent Technologies annual total liabilities was $5.99 B in 2025.

Capital Expenditure

Agilent Technologies annual capital expenditures was -$407.00 M in 2025.

Ratios

Return on Equity (ROE)

Agilent Technologies annual return on equity(ROE) was 6.44% in 2025.

Return on Assets (ROA)

Agilent Technologies annual return on assets(ROA) was 3.41% in 2025.

Debt to Equity

Agilent Technologies annual debt to equity was 49.76% in 2025.

Profitability

Gross Profit Margin (%)

Agilent Technologies annual gross profit margin was 52.43% in 2025.

Operating Income Margin (%)

Agilent Technologies annual operating income margin was 21.29% in 2025.

Net Income Margin (%)

Agilent Technologies annual net income margin was 18.75% in 2025.

Earning Per Share

Agilent Technologies annual earning per share was $4.60 in 2025.

EBITDA

Agilent Technologies annual EBITDA was $1.84 B in 2025.

Free Cash Flow (FCF)

Agilent Technologies annual free cash flow(FCF) was $1.15 B in 2025.

Valuation

Enterprise value

Agilent Technologies annual enterprise value was $42.98 B in 2025.

Enterprise value to Revenue

Agilent Technologies annual enterprise value to revenue was 23.10 in 2025.

Enterprise value to EBITDA

Agilent Technologies annual enterprise value to EBITDA was 58.80 in 2025.

Competitors’ Revenue

Frequently Asked Questions

When was Agilent Technologies founded?

Agilent Technologies was founded on 1999, which makes the company 27 years old.

Sign up for free to view

Who is the CEO of Agilent Technologies?

Padraig McDonnell is the CEO of Agilent Technologies.

What industry and sector is Agilent Technologies in?

Agilent Technologies operates in the Medical - Diagnostics & Research industry and the Healthcare sector.

What are Agilent Technologies's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0001090872
  • SIC (Standard Industrial Classification): 3826
  • ISIN (International Securities Identification Number): US00846U1016

Sign up for free to view

How many employees does Agilent Technologies have?

Agilent Technologies has 18,100 employees.

What is the revenue of Agilent Technologies?

In fiscal year 2025, Agilent Technologies generated a revenue of $6.95 Billion.

What is the net income of Agilent Technologies?

In fiscal year 2025, Agilent Technologies reported a net income of $1.30 Billion.

What is Agilent Technologies's biggest product segment?

Agilent CrossLab is Agilent Technologies's biggest product segment, representing 41.85% of its total revenue.

When was Agilent Technologies listed on the stock exchange?

Agilent Technologies went public on Nov 18, 1999, through its Initial Public Offering (IPO), and it has been 26 years since then.

Sign up for free to view

What is the ticker symbol of Agilent Technologies, and where is it listed?

Agilent Technologies's ticker symbol is A, and the company is listed on the NYSE stock market exchange.

What is Agilent Technologies's current stock price?

Agilent Technologies's current stock price is $134.01 as of Jul 14, 2026.

What is Agilent Technologies's market capitalization?

As of , Agilent Technologies's market cap is .

What is Agilent Technologies's ranking in the world?

Ranked #53among 2,804 companies based on market cap.

Who are the top competitors of Agilent Technologies?

Competitors of Agilent Technologies include Thermo Fisher Scientific and Danaher Corporation, and more.

People Also Search For

Submit feedback to Bullfincher